Home › Companies › REGENXBIO INC. › 2024-2025

REGENXBIO INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and REGENXBIO INC.’s Form 8-K, filed 2025-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 10Reported items
  • 160Asset managers
  • 1,473Fund votes
  • 2025-05-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore REGENXBIO INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by REGENXBIO INC.

These tallies are REGENXBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

REGENXBIO INC. — official shareholder meeting results, meeting held 2025-05-30
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Allan Fox 27,990,560---- 6,436,9856,854,844 Majority: yes
Elect Director: Alexandra Glucksmann, Ph.D. 29,264,825---- 5,162,7206,854,844 Majority: yes
Elect Director: Curran Simpson 32,802,148---- 1,625,3976,854,844 Majority: yes
Elect Director: Jennifer Zachary 29,179,798---- 5,247,7476,854,844 Majority: yes
Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025: 41,172,52239,37570,492 --0 Majority: yes
Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement: 32,577,6031,756,15593,787 --6,854,844 Majority: yes
Proposal 5: By the following vote, the stockholders approved, the REGENXBIO Inc 27,395,8026,974,24657,497 --6,854,844 Majority: yes

Source: REGENXBIO INC., Form 8-K, filed with the SEC on 2025-06-03 — read the filing on EDGAR.

How asset managers voted at the REGENXBIO INC. 2024-2025 meeting

Each item below shows how the 160 asset managers that disclosed a REGENXBIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REGENXBIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote on the compensation paid to the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 32,577,603AGAINST: 1,756,155

REGENXBIO INC.’s own tally for this item (“Proposal 3: By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”): 32,577,603 for, 1,756,155 against, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 65% for, 4% against (69% of the company cast a for/against vote).

The 159 asset managers below cast 98% of the shares they voted on this item FOR (29,620,113 for, 508,905 against).

FOR 98%
FOR: 29,620,113 (98.2%)AGAINST: 508,905 (1.7%)ABSTAIN: 19,693 (0.1%)
Largest asset managers voting on “Advisory vote on the compensation paid to the Company's named executive officers.” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan5,362,4800 00For
Redmile Group, LLC4,794,7800 00For
BlackRock4,579,39013,412 00For
Vanguard3,472,2840 00For
Fidelity1,212,3660 00For
GEODE CAPITAL MANAGEMENT, LLC1,106,8660 00For
State Street961,0397 00For
Dimensional754,6990 00For
Charles Schwab733,0980 00For
Integral Health Asset Management, LLC609,8960 00For
Exome Asset Management LLC396,7490 00For
BALYASNY ASSET MANAGEMENT L.P.392,2550 00For
Voss Capital, LP366,8360 00For
Northern Trust362,7390 00For
STIFEL NICOLAUS & CO INC \MO\351,7730 00For
Columbia Threadneedle329,1480 00For
Citadel323,6530 00For
Avidity Partners Management LP260,0000 00For
ArchPoint Investors218,4470 00For
American Century0203,126 00Against
MARSHALL WACE, LLP182,5240 00For
Two Sigma181,0090 00For
ADAR1 Capital Management, LLC179,9370 00For
Hudson Bay Capital Management LP177,6930 00For
Delaware/Macquarie149,0000 00For

Showing the 25 largest of 159 asset managers. See all 159 in the interactive database.

2. Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

1 YEAR 52.8%ONE YEAR 40%

The 151 asset managers below cast 99.9% of the shares they voted on this item FOR (997,413 for, 320 against).

FOR: 997,413 (3.8%)AGAINST: 320 (0.0%)ABSTAIN: 19,693 (0.1%)1 YEAR: 13,794,360 (52.8%)ONE YEAR: 10,524,380 (40.3%)THREE YEARS: 766,957 (2.9%)3 YEARS: 17,492 (0.1%)1-YEAR: 869 (0.0%)
Largest asset managers voting on “Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's ” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Redmile Group, LLC00 001 Year
BlackRock00 001 Year
Vanguard00 00One Year
JPMorgan00 001 Year
Fidelity00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
State Street00 00One Year
Dimensional00 00Three Years
Charles Schwab00 001 Year
Integral Health Asset Management, LLC609,8960 00For
BALYASNY ASSET MANAGEMENT L.P.00 001 Year
Voss Capital, LP366,8360 00For
Northern Trust00 001 Year
STIFEL NICOLAUS & CO INC \MO\00 00One Year
Columbia Threadneedle00 00One Year
Citadel00 00One Year
Avidity Partners Management LP00 001 Year
American Century00 00One Year
MARSHALL WACE, LLP00 001 Year
Two Sigma00 00One Year
ADAR1 Capital Management, LLC00 00One Year
Hudson Bay Capital Management LP00 00One Year
Delaware/Macquarie00 00One Year
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST00 00One Year
Point7200 00One Year

Showing the 25 largest of 151 asset managers. See all 151 in the interactive database.

3. Election of Four Class I Directors: Allan M. Fox

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD 19%
FOR: 27,990,560WITHHELD: 6,436,985

REGENXBIO INC.’s own tally for this item (“Elect Director: Allan Fox”): 27,990,560 for, 6,436,985 withheld, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 56% for, 13% withheld (69% of the company cast a for/withheld vote).

The 44 asset managers below cast 100% of the shares they voted on this item FOR (9,941,170 for, 0 against).

FOR 89%11%
FOR: 9,941,170 (89.1%)ABSTAIN: 1,217,446 (10.9%)
Largest asset managers voting on “Election of Four Class I Directors: Allan M. Fox” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,186,3640 00For
BlackRock2,500,4670 00For
JPMorgan1,978,7260 00For
Fidelity1,103,2660 00For
Dimensional00 622,8330Abstain
Charles Schwab366,5490 00For
Columbia Threadneedle329,1480 00For
Delaware/Macquarie00 149,0000Abstain
Equitable72,9170 52,9000For
TIAA111,3870 00For
American Century00 101,5630Abstain
Global X82,4040 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
State Street140 63,3640Abstain
Lincoln Financial00 39,1710Abstain
Brighthouse00 34,5920Abstain
MASTER INVESTMENT PORTFOLIO32,9450 00For
Northern Trust00 32,6890Abstain
Invesco25,3250 00For
AIG/SunAmerica00 23,0160Abstain
Pacific Life22,9480 00For
Bridge Builder Trust20,6960 00For
John Hancock00 19,1890Abstain
Jackson National00 13,6720Abstain
ProShares00 13,1540Abstain

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

4. Election of Four Class I Directors: Curran Simpson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 32,802,148WITHHELD: 1,625,397

REGENXBIO INC.’s own tally for this item (“Elect Director: Curran Simpson”): 32,802,148 for, 1,625,397 withheld, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 65% for, 3% withheld (69% of the company cast a for/withheld vote).

The 44 asset managers below cast 100% of the shares they voted on this item FOR (10,337,806 for, 0 against).

FOR 93%7%
FOR: 10,337,806 (92.6%)ABSTAIN: 820,810 (7.4%)
Largest asset managers voting on “Election of Four Class I Directors: Curran Simpson” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,186,3640 00For
BlackRock2,500,4670 00For
JPMorgan1,978,7260 00For
Fidelity1,103,2660 00For
Dimensional00 622,8330Abstain
Charles Schwab366,5490 00For
Columbia Threadneedle329,1480 00For
Delaware/Macquarie00 149,0000Abstain
Equitable125,8170 00For
TIAA111,3870 00For
American Century101,5630 00For
Global X82,4040 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
State Street63,3780 00For
Lincoln Financial34,1000 5,0710For
Brighthouse15,1490 19,4430Abstain
MASTER INVESTMENT PORTFOLIO32,9450 00For
Northern Trust32,6890 00For
Invesco25,3250 00For
AIG/SunAmerica23,0160 00For
Pacific Life22,9480 00For
Bridge Builder Trust20,6960 00For
John Hancock17,3440 1,8450For
Jackson National00 13,6720Abstain
ProShares13,1540 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

5. Election of Four Class I Directors: Jennifer Zachary

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 29,179,798WITHHELD: 5,247,747

REGENXBIO INC.’s own tally for this item (“Elect Director: Jennifer Zachary”): 29,179,798 for, 5,247,747 withheld, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 58% for, 10% withheld (69% of the company cast a for/withheld vote).

The 44 asset managers below cast 100% of the shares they voted on this item FOR (10,074,167 for, 0 against).

FOR 90%10%
FOR: 10,074,167 (90.3%)ABSTAIN: 1,084,449 (9.7%)
Largest asset managers voting on “Election of Four Class I Directors: Jennifer Zachary” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,186,3640 00For
BlackRock2,500,4670 00For
JPMorgan1,978,7260 00For
Fidelity1,103,2660 00For
Dimensional00 622,8330Abstain
Charles Schwab366,5490 00For
Columbia Threadneedle329,1480 00For
Delaware/Macquarie00 149,0000Abstain
Equitable72,9170 52,9000For
TIAA111,3870 00For
American Century00 101,5630Abstain
Global X82,4040 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
State Street63,3670 110For
Lincoln Financial34,1000 5,0710For
Brighthouse00 34,5920Abstain
MASTER INVESTMENT PORTFOLIO32,9450 00For
Northern Trust32,6890 00For
Invesco25,3250 00For
AIG/SunAmerica00 23,0160Abstain
Pacific Life22,9480 00For
Bridge Builder Trust20,6960 00For
John Hancock00 19,1890Abstain
Jackson National00 13,6720Abstain
ProShares00 13,1540Abstain

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

6. To approve the REGENXBIO Inc. 2025 Equity Incentive Plan.

COMPENSATIONMajority of the votes cast: yes

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%
FOR: 27,395,802AGAINST: 6,974,246

REGENXBIO INC.’s own tally for this item (“Proposal 5: By the following vote, the stockholders approved, the REGENXBIO Inc”): 27,395,802 for, 6,974,246 against, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 54.7% for, 14% against (69% of the company cast a for/against vote).

The 44 asset managers below cast 85% of the shares they voted on this item FOR (9,475,477 for, 1,683,139 against).

FOR 85%AGAINST 15%
FOR: 9,475,477 (84.9%)AGAINST: 1,683,139 (15.1%)
Largest asset managers voting on “To approve the REGENXBIO Inc. 2025 Equity Incentive Plan.” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,186,3640 00For
BlackRock2,500,4670 00For
JPMorgan1,978,7260 00For
Fidelity996,063107,203 00For
Dimensional0622,833 00Against
Charles Schwab366,5490 00For
Columbia Threadneedle0329,148 00Against
Delaware/Macquarie0149,000 00Against
Equitable72,91752,900 00For
TIAA0111,387 00Against
American Century0101,563 00Against
Global X82,4040 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
State Street63,36711 00For
Lincoln Financial34,1005,071 00For
Brighthouse19,44315,149 00For
MASTER INVESTMENT PORTFOLIO32,9450 00For
Northern Trust032,689 00Against
Invesco025,325 00Against
AIG/SunAmerica023,016 00Against
Pacific Life22,9480 00For
Bridge Builder Trust20,6960 00For
John Hancock019,189 00Against
Jackson National013,672 00Against
ProShares013,154 00Against

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

7. To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 41,172,522AGAINST: 39,375

REGENXBIO INC.’s own tally for this item (“Proposal 2: By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025:”): 41,172,522 for, 39,375 against, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 82% for, 0.1% against (82% of the company cast a for/against vote).

The 44 asset managers below cast 99.9% of the shares they voted on this item FOR (11,139,172 for, 1 against).

FOR 99.8%
FOR: 11,139,172 (99.8%)AGAINST: 1 (0.0%)ABSTAIN: 19,443 (0.2%)
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as th” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,186,3640 00For
BlackRock2,500,4670 00For
JPMorgan1,978,7260 00For
Fidelity1,103,2660 00For
Dimensional622,8330 00For
Charles Schwab366,5490 00For
Columbia Threadneedle329,1480 00For
Delaware/Macquarie149,0000 00For
Equitable125,8170 00For
TIAA111,3870 00For
American Century101,5630 00For
Global X82,4040 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
State Street63,3771 00For
Lincoln Financial39,1710 00For
Brighthouse15,1490 19,4430Abstain
MASTER INVESTMENT PORTFOLIO32,9450 00For
Northern Trust32,6890 00For
Invesco25,3250 00For
AIG/SunAmerica23,0160 00For
Pacific Life22,9480 00For
Bridge Builder Trust20,6960 00For
John Hancock19,1890 00For
Jackson National13,6720 00For
ProShares13,1540 00For

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

8. Election of Four Class I Directors: Alexandra Glucksmann, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 29,264,825WITHHELD: 5,162,720

REGENXBIO INC.’s own tally for this item (“Elect Director: Alexandra Glucksmann, Ph.D.”): 29,264,825 for, 5,162,720 withheld, per its Form 8-K filed 2025-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,117,000 outstanding shares: 58% for, 10% withheld (69% of the company cast a for/withheld vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (5,461,673 for, 0 against).

FOR 84%ABSTAIN 16%
FOR: 5,461,673 (83.9%)ABSTAIN: 1,049,829 (16.1%)
Largest asset managers voting on “Election of Four Class I Directors: Alexandra Glucksmann, Ph.D.” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,186,3640 00For
Fidelity1,103,2660 00For
Dimensional00 622,8330Abstain
Charles Schwab366,5490 00For
Columbia Threadneedle329,1480 00For
Delaware/Macquarie00 149,0000Abstain
Equitable72,9170 52,9000For
TIAA111,3870 00For
American Century00 101,5630Abstain
Global X82,4040 00For
State Street63,3670 110For
Lincoln Financial34,1000 5,0710For
Brighthouse00 34,5920Abstain
Northern Trust32,6890 00For
Invesco25,3250 00For
AIG/SunAmerica00 23,0160Abstain
Pacific Life22,9480 00For
ProShares00 13,1540Abstain
ETFis Series Trust I00 10,5280Abstain
T. Rowe Price10,2880 00For
SEI9,3000 00For
Prudential/PGIM00 7,1870Abstain
Voya00 7,0840Abstain
DWS00 6,9230Abstain
Nationwide6,2170 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

9. DIRECTOR: Alexandra G. Ph.D.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 99.2%

The 9 asset managers below cast 100% of the shares they voted on this item FOR (4,612,494 for, 0 against).

FOR: 4,612,494 (99.3%)ABSTAIN: 34,620 (0.7%)
Largest asset managers voting on “DIRECTOR: Alexandra G. Ph.D.” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock2,500,4670 00For
JPMorgan1,978,7260 00For
QUANTITATIVE MASTER SERIES LLC79,4420 00For
MASTER INVESTMENT PORTFOLIO32,9450 00For
Bridge Builder Trust20,6960 00For
John Hancock00 19,1890Abstain
Jackson National00 13,6720Abstain
Allianz00 1,7590Abstain
WILSHIRE MUTUAL FUNDS INC2180 00For

10. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

ONE YEAR 99.9%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (100 for, 0 against).

FOR: 100 (0.0%)ONE YEAR: 3,376,854 (100.0%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at REGENXBIO INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan00 00One Year
TD ASSET MANAGEMENT INC1000 00For

Largest REGENXBIO INC. shareholders voting in 2024-2025

Ranked by the number of REGENXBIO INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 50,117,000 shares outstanding at the time of that meeting.

Top REGENXBIO INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1JPMorgan 10.70%
2Redmile Group, LLC 9.57%
3BlackRock 9.16%
4Vanguard 6.93%
5Fidelity 2.42%
6GEODE CAPITAL MANAGEMENT, LLC 2.21%
7State Street 1.92%
8Dimensional 1.51%
9Charles Schwab 1.46%
10Integral Health Asset Management, LLC 1.22%

Reported REGENXBIO INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

REGENXBIO INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 10.88% 13F
Redmile Group, LLC 10.10% 13G
JPMorgan Chase 8.71% 13F
Vanguard Group 6.93% 13F
Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company 5.75% DEF14A
Morgan Stanley 4.12% 13F
Dimensional Fund Advisors 2.29% 13F
Geode Capital 2.21% 13F
Citadel Advisors 2.14% 13F
State Street 2.13% 13F

Percentages above are of 50,117,000 shares outstanding, as reported by REGENXBIO INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At REGENXBIO INC.'s shareholder meeting held 2025-05-30, in the 2024-2025 proxy season, 160 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,473 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation paid to the Company's named executive officers. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: REGENXBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-03.

REGENXBIO INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.